Type i β-lactamases of gram-negative bacteria: Interactions with β-lactam antibiotics

Journal of Infectious Diseases

Volumn 154, Issue 5, 1986, Pages 792-800

  Sanders, Christine C ^a,b   Sanders, W Eugene ^a,b  

^a Department of Medical Microbiology ^*  (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 CARBAMOYLOXYETHYLTHIO) 6 (1 HYDROXYETHYL)PENEM 3 CARBOXYLIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALOTIN; CEFAMANDOLE; CEFEPIME; CEFMETAZOLE; CEFONICID; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN; CLAVULANIC ACID; DEACETYLCEFOTAXIME; IMIPENEM; LATAMOXEF; NITROCEFIN; PENICILLINASE; SULBACTAM;

DRUG INTERACTION; DRUG RESISTANCE; ENTEROBACTERIACEAE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTIBIOTICS, LACTAM; BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; HYDROLYSIS; MICROBIAL SENSITIVITY TESTS; MUTATION; SUPPORT, NON-U.S. GOV'T;

EID: 0023007816     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/154.5.792     Document Type: Article

References (47)

1. Richmond MH, Sykes RB. The p-lactamases of gram-negative bacteria and their possible physiological role. Adv Microb Physiol 1973;9:31-88
2. Sykes RB, Matthew M. The B-lactamases of gram-negative bacteria and their role in resistance to 3-lactam antibiot-ics. J Antimicrob Chemother 1979;2:115-57
3. Brodgen RN, Carmine A, Heel RC, Morley PA, Speight TM, Avery GS. Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics, and therapeutic use. Drugs 1981;22:337-62
4. Sanders CC, Sanders WE Jr. Emergence of resistance to cefamandole: possible role of ceftoxitin-inducible P-lacta- mases. Antimicrob Agents Chemother 1979;15:792-7
5. Minami S, Yotsuji A, Inoue M, Mitsuhashi S. Induction of 3-lactamase by various beta-lactam antibiotics in Entero- bacter cloacae. Antimicrob Agents Chemother 1980;18: 382-5
6. Tausk F, Evans ME, Patterson LS, Federspiel CF, Stratton CW. Imipenem-induced resistance to antipseudomonal p- lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1985;28:41-5
7. Findell CM, Sherris JC. Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resis-tance. Antimicrob Agents Chemother 1976;9:970-4
8. Sanders CC, Sanders WE Jr. Microbial resistance to newer generation 3-lactam antibiotics: clinical and laboratory implications. J Infect Dis 1985;151:399-406
9. Goering RV, Ruff EA. Comparative analysis of conjugative plasmids mediating gentamicin resistance in Staphylococ-cus aureus. Antimicrob Agents Chemother 1983;24:450-2
10. Steers E, Foltz EL, Graves BS, with the assistance of Riden J. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot Chemother 1959;9:307-11
11. Gootz TD, Sanders CC, Goering RV. Resistance to cefamandole: derepression of 3-lactamase by cefoxitin and muta-tion in Enterobacter cloacae. J Infect Dis 1982;146:34-42
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54
13. Okonogi K, Sugiura A, Kuno M, Higashide E, Kondo M, Imada A. Effect of 3-lactamase induction on susceptibil-ity to cephalosporins in Enterobacter cloacae and Serra- tia marcescens. J Antimicrob Chemother 1985;16:31-42
14. Yotsuji A, Minami S, Araki Y, Inoue M, Mitsuhashi S. Inducer activity of 3-lactam antibiotics for the 3-lactamases of Proteus rettgeri and Proteus vulgaris. J Antibiot 1982;35:1590-3
15. Mouton RP, van Gestel M, Bongaerts GPA. Absence of 3- lactamase-inducing effect of moxalactam. Rev Infect Dis 1982;4:S527-8
16. Grappel SF, Giovenella AJ, Newman DJ, Nisbet LIP. Lactamase induction by A'-formimidoylthienamycin. J Antibiot 1984;37:1101-2
17. Sykes RB, Bonner DP. Discovery and development of the monobactams. Rev Infect Dis 1985;7:S579-604
18. Bush K, Sykes RB. Interaction of 3-lactam antibiotics with P-lactamases as a cause for resistance. In: Bryan LE, ed. Antimicrobial drug resistance. Orlando, Fla: Academic Press, 1984:1-31
19. Waterworth PM, Emmerson AM. Dissociated resistance among cephalosporins. Antimicrob Agents Chemother 1979;15:497-503
20. Grimm H. Bacteriological antagonism between acylureido- penicillins and cephalosporins. J Antimicrob Chemother 1982;9(Suppl):31-4
21. Sanders CC, Sanders WE Jr, Goering RV. In vitro antagonism of beta-lactam antibiotics by cefoxitin. Antimicrob Agents Chemother 1982;21:968-75
22. Miller MA, Finan M, Yousuf M. In-vitro antagonism by N- formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens. J Antimicrob Chemother 1983;11: 311-8
23. Moellering RC Jr., Willey S, Eliopoulos GM. Synergism and antagonism of ceftizoxime and other new cephalosporins. J Antimicrob Chemother 1982;10(Suppl):69-79
24. Neu HC, Labthavikul P. Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoper- azone, cefotaxime and moxalactam. J Antimicrob Chemother 1982;9(Suppl):101-6
25. Kuck NA, Testa RT, Forbes M. In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiot-ics. Antimicrob Agents Chemother 1981;19:634-8
26. Goering RV, Sanders CC, Sanders WE Jr. Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice. Antimicrob Agents Chemother 1982;21:963-7
27. Minami S, Matsubara N, Yotsuji A, Araki H, Watanabe Y, Yasuda T, Saikawa I, Mitsuhashi S. Induction of cephalosporinase production by various penicillins in En- terbacteriaceae. J Antibiot 1983;36:1387-95
28. Furth A. The beta-lactamases of Pseudomonas aeruginosa. In: Hamilton-Miller JMT, Smith JT, eds. Beta-lactamases. New York: Academic Press, 1979:403-28
29. Jacobs J Y, Livermore DM, Davy K WM. Pseudomonas aeruginosa P-lactamase as a defense against azlocillin, mezlocillin and piperacillin. J Antimicrob Chemother 1984;14:221-9
30. Livermore DM, Williams JD, Davy KW. Cephalosporin resistance in Pseudomonas aeruginosa, with special refer-ence to the proposed trapping of antibiotics by beta- lactamase. Chemioterapia 1985;4:28-35
31. Gootz TD, Sanders CC. Characterization of 3-lactamase induction in Enterobacter cloacae. Antimicrob Agents Chemother 1983;23:91-7
32. Livermore DM. Kinetics and significance of the activity of the Sabath and Abrahams’ 3-lactamase of Pseudomonas aeruginosa against cefotaxime and cefsulodin. J An-timicrob Chemother 1983;11:169-79
33. Jones RN, Barry AL, Thornsberry C. Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy. Rev Infect Dis 1982;4: S366-73
34. Neu HC. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime. Rev Infect Dis 1982;4:S374-8
35. Calderwood SB, Gardella A, Philippon AM, Jacoby GA, Moellering RC Jr. Effects of azlocillin in combination with clavulanic acid, sulbactam, and /v'-formimidoyl thienamy- cin against p-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1982;22:266-71
36. Sanders CC, Sanders WE Jr. Trapping and hydrolysis are not mutually exclusive mechanisms for p-lactamase-mediated resistance. J Antimicrob Chemother 1986;17:121-7
37. Vu H, Nikaido H. Role of p-lactam hydrolysis in the mechanism of resistance of a P-lactamase-constitutive Enterobac- ter cloacae strain to expanded-spectrum P-lactams. Antimicrob Agents Chemother 1985;27:393-8
38. Yoshimura F, Nikaido H. Diffusion of p-lactam antibiotics through the porin channels of Escherichia coli K- 12. An-timicrob Agents Chemother 1985;27:84-92
39. Sawai T, Hiruma R, Kawana N, Kaneko M, Taniyasu F, Inami A. Outer membrane permeation of p-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae. Antimicrob Agents Chemother 1982;22:585-92
40. Sawai T, Matsuba K, Tamura A, Yamagishi S. The bacterial outer-membrane permeability of P-lactam antibiotics, J Antibiotics 1979;32:59-65
41. Biagi GL, Guerra MC, Barbaro AM, Gamba MF. Influence of lipophilic character on the antibacterial activity of ceph-alosporins and penicillins. J Med Chem 1970;13:511-6
42. Yoshimura F, Nikaido H. Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. J Bacteriol 1982;152:636-42
43. Kojo H, Shigi Y, Nishida M. Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives. J Antibiotics 1980;33:317-21
44. Tolxdorff-Neutzling RM, Wiedemann B. HR 810, a cephalosporin with low affinity for Enterobacter cloacae beta-lac- tamase. Eur J Clin Microbiol 1983;2:352-4
45. Tomasz A. From penicillin-binding protein to the lysis and death of bacteria: a 1979 view. Rev Infect Dis 1979;1:434-67
46. Neu HC. Penicillin-binding proteins and role of amdinocil- lin in causing bacterial cell death. Am J Med 1983;75:9-20
47. Piddock LJ, Wise R. The mode of action of Sch 34343: Affinity for the penicillin binding proteins of Escherichia coli K-12 and Bacteroides fragilis. J Anti Chemo 1985:15 (Suppl):5-14